Pascale Exer
Overview
Explore the profile of Pascale Exer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
372
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Hebeisen M, Micheroli R, Scherer A, Baraliakos X, de Hooge M, van der Heijde D, et al.
PLoS One
. 2020 Mar;
15(3):e0230268.
PMID: 32196530
Objective: To investigate whether spinal radiographic progression relates to structural damage at the sacroiliac level in axial spondyloarthritis (axSpA). Methods: Patients classified as nonradiographic (nr-) and radiographic (r-) axSpA in...
12.
Hebeisen M, Scherer A, Micheroli R, Nissen M, Tamborrini G, Moller B, et al.
PLoS One
. 2019 May;
14(5):e0216746.
PMID: 31145730
Objectives: To compare drug survival in patients with axial spondyloarthritis treated with different TNF inhibitors in standard dosage. Methods: Patients fulfilling the Assessment in SpondyloArthritis international Society classification criteria for...
13.
Hebeisen M, Neuenschwander R, Scherer A, Exer P, Weber U, Tamborrini G, et al.
J Rheumatol
. 2018 Feb;
45(4):506-512.
PMID: 29449504
Objective: To investigate sex differences in connection with the effectiveness of tumor necrosis factor inhibitors (TNFi) in patients with ankylosing spondylitis (AS). Methods: A total of 440 patients with AS...
14.
Molnar C, Scherer A, Baraliakos X, de Hooge M, Micheroli R, Exer P, et al.
Ann Rheum Dis
. 2017 Sep;
77(1):63-69.
PMID: 28939631
Objectives: To analyse the impact of tumour necrosis factor inhibitors (TNFis) on spinal radiographic progression in ankylosing spondylitis (AS). Methods: Patients with AS in the Swiss Clinical Quality Management cohort...
15.
Micheroli R, Hebeisen M, Wildi L, Exer P, Tamborrini G, Bernhard J, et al.
Arthritis Res Ther
. 2017 Jul;
19(1):164.
PMID: 28724442
Background: Few studies have investigated the impact of obesity on the response to tumor necrosis factor inhibitors (TNFi) in patients with axial spondyloarthritis (axSpA). The aim of our study was...
16.
Nissen M, Ciurea A, Bernhard J, Tamborrini G, Mueller R, Weiss B, et al.
Arthritis Rheumatol
. 2016 Mar;
68(9):2141-50.
PMID: 27015429
Objective: To explore the effect of comedication with conventional synthetic disease-modifying antirheumatic drugs (DMARDs) on drug retention and clinical effectiveness of tumor necrosis factor inhibitors (TNFi) in patients with axial...
17.
Ciurea A, Exer P, Weber U, Tamborrini G, Steininger B, Kissling R, et al.
Arthritis Res Ther
. 2016 Mar;
18:71.
PMID: 27000865
Background: With regard to switching tumor necrosis factor inhibitors (TNFi) in axial spondyloarthritis (axSpA), conflicting results have been reported as to whether the effectiveness of a second TNFi depends on...
18.
Ciurea A, Scherer A, Weber U, Exer P, Bernhard J, Tamborrini G, et al.
Ann Rheum Dis
. 2015 Feb;
75(3):532-9.
PMID: 25667205
Objectives: To investigate the impact of smoking on the response to treatment with a first tumour necrosis factor inhibitor (TNFi) in patients with axial spondyloarthritis (axSpA) in a real-life cohort....
19.
Ciurea A, Weber U, Stekhoven D, Scherer A, Tamborrini G, Bernhard J, et al.
J Rheumatol
. 2014 Nov;
42(1):101-5.
PMID: 25362654
Objective: To evaluate the initiation of and response to tumor necrosis factor (TNF) inhibitors for axial spondyloarthritis (axSpA) in private rheumatology practices versus academic centers. Methods: We compared newly initiated...
20.
Ciurea A, Scherer A, Weber U, Neuenschwander R, Tamborrini G, Exer P, et al.
Ann Rheum Dis
. 2014 Aug;
73(10):1908-10.
PMID: 25104774
No abstract available.